Article citationsMore>>
Gine, E., Martinez, A., Villamor, N., Lopez-Guillermo, A., Camos, M., Martinez, D., Esteve, J., Calvo, X., Muntanola, A., Abrisqueta, P., Rozman, M., Rozman, C., Bosch, F., Campo, E. and Montserrat, E. (2010) Expanded and Highly Active Proliferation Centers Identify a Histological Subtype of Chronic Lymphocytic Leukemia (“Accelerated” Chronic Lymphocytic Leukemia) with Aggressive Clinical Behavior. Haematologica, 95, 1526-1533.
https://doi.org/10.3324/haematol.2010.022277
has been cited by the following article:
-
TITLE:
A Rare Entity of Accelerated Chronic Lymphocytic Leukemia: A Report of Two Cases and Review of Literature
AUTHORS:
Zahra Kmira, Ben Yahya Noura, Chembah Wafa, Ben Sayed Nesrine, Chiba Dorra, Bouteraa Walid, Zaier Monia, Ben Youssef Yosra, Haifa Regaieg, Khelif Abderrahim
KEYWORDS:
Accelerated Chronic Lymphocytic Leukemia, Richter Transformation, Prognosis, Treatment
JOURNAL NAME:
Health,
Vol.15 No.8,
August
22,
2023
ABSTRACT: Background: Accelerated-chronic lymphocytic leukemia (A-CLL) is a rare disease entity as it represents less than 1% of all reported cases of chronic lymphoid leukemia (CLL). Moreover, it is most likely an under diagnosed entity due to its rarity and the non-standardized practice of lymph node biopsy in CLL. Purpose: The aims of our work are to establish the diagnosis of A-CLL and to study the prognosis and treatment of this rare entity. Method: here, we report the clinical presentation and the follow up of two cases of A-CLL. Results: Distinguishing Richter transformation (RT) from A-CLL is important as it may result in a major change in disease management. The prognosis of A-CLL is intermediate between CLL and RT. The prognosis is mainly poor due to a predominance of poor prognostic markers including an increasing number of p53-positive cases. Conclusion: To this date, no prospective study has been led to define the best treatment for A-CLL. The shorter survival of A-CLL when compared to typical CLL implies the need of a more aggressive treatment.